 | • レポートコード：MRC2-11QY04406 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乾癬治療薬のグローバル市場について調査・分析したレポートです。種類別（TNF阻害剤、PDE4阻害剤、インターロイキン遮断薬、その他）市場規模、用途別（経口、非経口、局所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乾癬治療薬の競争状況、市場シェア ・世界の乾癬治療薬市場：種類別市場規模 2015年-2020年（TNF阻害剤、PDE4阻害剤、インターロイキン遮断薬、その他） ・世界の乾癬治療薬市場：種類別市場規模予測 2021年-2026年（TNF阻害剤、PDE4阻害剤、インターロイキン遮断薬、その他） ・世界の乾癬治療薬市場：用途別市場規模 2015年-2020年（経口、非経口、局所） ・世界の乾癬治療薬市場：用途別市場規模予測 2021年-2026年（経口、非経口、局所） ・北米の乾癬治療薬市場分析：米国、カナダ ・ヨーロッパの乾癬治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乾癬治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乾癬治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乾癬治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma Inc.、AstraZeneca plc、Boehringer Ingelheim GmbH、F. Hofffmann-La Roche、GlaxoSmithKline plc、Merck & Co., Inc.、Valeant Pharmaceuticals International, Inc.、Biocon Limited、Eli Lilly and Company、G & W Laboratories Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
Market Analysis and Insights: Global Psoriasis Therapeutics Market
The global Psoriasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Psoriasis Therapeutics Scope and Market Size
Psoriasis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.
Market segment by Type, the product can be split into
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
Market segment by Application, split into
Oral
Parenteral
Topical
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 TNF Inhibitors
1.4.3 PDE4 Inhibitors
1.4.4 Interleukin Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Oral
1.5.3 Parenteral
1.5.4 Topical
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2015-2026)
2.2 Global Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Psoriasis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Psoriasis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Market Size
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriasis Therapeutics Market Concentration Ratio
3.2.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2019
3.3 Psoriasis Therapeutics Key Players Head office and Area Served
3.4 Key Players Psoriasis Therapeutics Product Solution and Service
3.5 Date of Enter into Psoriasis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Psoriasis Therapeutics Market Size by Application (2015-2020)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2015-2020)
6.2 Psoriasis Therapeutics Key Players in North America (2019-2020)
6.3 North America Psoriasis Therapeutics Market Size by Type (2015-2020)
6.4 North America Psoriasis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2015-2020)
7.2 Psoriasis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Psoriasis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Psoriasis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Psoriasis Therapeutics Market Size (2015-2020)
8.2 Psoriasis Therapeutics Key Players in China (2019-2020)
8.3 China Psoriasis Therapeutics Market Size by Type (2015-2020)
8.4 China Psoriasis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Psoriasis Therapeutics Market Size (2015-2020)
9.2 Psoriasis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Psoriasis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Psoriasis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Psoriasis Therapeutics Market Size (2015-2020)
10.2 Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Psoriasis Therapeutics Market Size (2015-2020)
11.2 Psoriasis Therapeutics Key Players in India (2019-2020)
11.3 India Psoriasis Therapeutics Market Size by Type (2015-2020)
11.4 India Psoriasis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Psoriasis Therapeutics Market Size (2015-2020)
12.2 Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Details
13.1.2 Astellas Pharma Inc. Business Overview
13.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
13.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020))
13.1.5 Astellas Pharma Inc. Recent Development
13.2 AstraZeneca plc
13.2.1 AstraZeneca plc Company Details
13.2.2 AstraZeneca plc Business Overview
13.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
13.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020)
13.2.5 AstraZeneca plc Recent Development
13.3 Boehringer Ingelheim GmbH
13.3.1 Boehringer Ingelheim GmbH Company Details
13.3.2 Boehringer Ingelheim GmbH Business Overview
13.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
13.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020)
13.3.5 Boehringer Ingelheim GmbH Recent Development
13.4 F. Hofffmann-La Roche
13.4.1 F. Hofffmann-La Roche Company Details
13.4.2 F. Hofffmann-La Roche Business Overview
13.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
13.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020)
13.4.5 F. Hofffmann-La Roche Recent Development
13.5 GlaxoSmithKline plc
13.5.1 GlaxoSmithKline plc Company Details
13.5.2 GlaxoSmithKline plc Business Overview
13.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
13.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020)
13.5.5 GlaxoSmithKline plc Recent Development
13.6 Merck & Co., Inc.
13.6.1 Merck & Co., Inc. Company Details
13.6.2 Merck & Co., Inc. Business Overview
13.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
13.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
13.6.5 Merck & Co., Inc. Recent Development
13.7 Valeant Pharmaceuticals International, Inc.
13.7.1 Valeant Pharmaceuticals International, Inc. Company Details
13.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
13.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
13.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
13.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
13.8 Biocon Limited
13.8.1 Biocon Limited Company Details
13.8.2 Biocon Limited Business Overview
13.8.3 Biocon Limited Psoriasis Therapeutics Introduction
13.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020)
13.8.5 Biocon Limited Recent Development
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Details
13.9.2 Eli Lilly and Company Business Overview
13.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
13.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020)
13.9.5 Eli Lilly and Company Recent Development
13.10 G & W Laboratories Inc.
13.10.1 G & W Laboratories Inc. Company Details
13.10.2 G & W Laboratories Inc. Business Overview
13.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
13.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
13.10.5 G & W Laboratories Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Psoriasis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Psoriasis Therapeutics Revenue
Table 3. Ranking of Global Top Psoriasis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TNF Inhibitors
Table 6. Key Players of PDE4 Inhibitors
Table 7. Key Players of Interleukin Blockers
Table 8. Key Players of Others
Table 9. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Psoriasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Psoriasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Psoriasis Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Psoriasis Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Psoriasis Therapeutics Players
Table 20. Global Psoriasis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Psoriasis Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019)
Table 23. Global Psoriasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Psoriasis Therapeutics Product Solution and Service
Table 26. Date of Enter into Psoriasis Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Psoriasis Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Psoriasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Psoriasis Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Psoriasis Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 36. North America Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 38. North America Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 42. Europe Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 48. China Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 50. China Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 54. Japan Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 66. India Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 68. India Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 72. Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 76. Astellas Pharma Inc. Company Details
Table 77. Astellas Pharma Inc. Business Overview
Table 78. Astellas Pharma Inc. Product
Table 79. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 80. Astellas Pharma Inc. Recent Development
Table 81. AstraZeneca plc Company Details
Table 82. AstraZeneca plc Business Overview
Table 83. AstraZeneca plc Product
Table 84. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 85. AstraZeneca plc Recent Development
Table 86. Boehringer Ingelheim GmbH Company Details
Table 87. Boehringer Ingelheim GmbH Business Overview
Table 88. Boehringer Ingelheim GmbH Product
Table 89. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 90. Boehringer Ingelheim GmbH Recent Development
Table 91. F. Hofffmann-La Roche Company Details
Table 92. F. Hofffmann-La Roche Business Overview
Table 93. F. Hofffmann-La Roche Product
Table 94. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 95. F. Hofffmann-La Roche Recent Development
Table 96. GlaxoSmithKline plc Company Details
Table 97. GlaxoSmithKline plc Business Overview
Table 98. GlaxoSmithKline plc Product
Table 99. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline plc Recent Development
Table 101. Merck & Co., Inc. Company Details
Table 102. Merck & Co., Inc. Business Overview
Table 103. Merck & Co., Inc. Product
Table 104. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 105. Merck & Co., Inc. Recent Development
Table 106. Valeant Pharmaceuticals International, Inc. Company Details
Table 107. Valeant Pharmaceuticals International, Inc. Business Overview
Table 108. Valeant Pharmaceuticals International, Inc. Product
Table 109. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 110. Valeant Pharmaceuticals International, Inc. Recent Development
Table 111. Biocon Limited Business Overview
Table 112. Biocon Limited Product
Table 113. Biocon Limited Company Details
Table 114. Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 115. Biocon Limited Recent Development
Table 116. Eli Lilly and Company Company Details
Table 117. Eli Lilly and Company Business Overview
Table 118. Eli Lilly and Company Product
Table 119. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 120. Eli Lilly and Company Recent Development
Table 121. G & W Laboratories Inc. Company Details
Table 122. G & W Laboratories Inc. Business Overview
Table 123. G & W Laboratories Inc. Product
Table 124. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 125. G & W Laboratories Inc. Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Others Features
Figure 6. Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Oral Case Studies
Figure 8. Parenteral Case Studies
Figure 9. Topical Case Studies
Figure 10. Psoriasis Therapeutics Report Years Considered
Figure 11. Global Psoriasis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Psoriasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Psoriasis Therapeutics Market Share by Players in 2019
Figure 16. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2019
Figure 18. North America Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…- 慢性尋常性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…
- 尋常性乾癬治療の世界市場（～2026年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…
- 局所疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Topical Pain Management Therapeutics Market The global Topical Pain Management Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Topical Pain Management Therapeutics Scop…
- 強皮症診断・治療の世界市場（～2026年） Market Analysis and Insights: Global Scleroderma Diagnostics and Therapeutics Market The global Scleroderma Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Scleroderma Diagnostics and Thera…